Gene Symbol | Gene ID | Gene Info |
---|---|---|
ZSCAN4
|
ENSG00000180532.6 | zinc finger and SCAN domain containing 4 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr19_58175542_58175994 | ZSCAN4 | 4535 | 0.104177 | 0.47 | 2.0e-01 | Click! |
chr19_58176040_58176274 | ZSCAN4 | 4146 | 0.107461 | 0.44 | 2.4e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr3_133748166_133748506 | 1.32 |
SLCO2A1 |
solute carrier organic anion transporter family, member 2A1 |
422 |
0.9 |
chr2_206549618_206550045 | 1.29 |
NRP2 |
neuropilin 2 |
1816 |
0.48 |
chr5_92921472_92921639 | 0.97 |
ENSG00000237187 |
. |
201 |
0.94 |
chr2_216297601_216297993 | 0.97 |
FN1 |
fibronectin 1 |
2993 |
0.27 |
chr12_108991532_108991806 | 0.96 |
TMEM119 |
transmembrane protein 119 |
115 |
0.95 |
chr2_167232459_167233133 | 0.95 |
SCN9A |
sodium channel, voltage-gated, type IX, alpha subunit |
293 |
0.93 |
chr19_16179581_16179939 | 0.93 |
TPM4 |
tropomyosin 4 |
1250 |
0.44 |
chr14_86000741_86001075 | 0.89 |
FLRT2 |
fibronectin leucine rich transmembrane protein 2 |
4336 |
0.28 |
chr10_7670560_7670711 | 0.86 |
ITIH5 |
inter-alpha-trypsin inhibitor heavy chain family, member 5 |
9012 |
0.26 |
chr6_56707059_56707245 | 0.85 |
DST |
dystonin |
791 |
0.6 |
chr1_182993880_182994112 | 0.84 |
LAMC1 |
laminin, gamma 1 (formerly LAMB2) |
1401 |
0.44 |
chr2_33360890_33361153 | 0.83 |
LTBP1 |
latent transforming growth factor beta binding protein 1 |
1297 |
0.6 |
chr18_32290517_32290846 | 0.82 |
DTNA |
dystrobrevin, alpha |
420 |
0.9 |
chr11_12309017_12309498 | 0.81 |
MICALCL |
MICAL C-terminal like |
810 |
0.62 |
chr4_77356777_77357012 | 0.80 |
SHROOM3 |
shroom family member 3 |
641 |
0.68 |
chr2_190041307_190041749 | 0.79 |
COL5A2 |
collagen, type V, alpha 2 |
3077 |
0.31 |
chr3_87036535_87037613 | 0.78 |
VGLL3 |
vestigial like 3 (Drosophila) |
2778 |
0.42 |
chr5_155754238_155754771 | 0.77 |
SGCD |
sarcoglycan, delta (35kDa dystrophin-associated glycoprotein) |
737 |
0.81 |
chr22_46473276_46473626 | 0.77 |
FLJ27365 |
hsa-mir-4763 |
2741 |
0.14 |
chr12_2163394_2163601 | 0.75 |
CACNA1C |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
768 |
0.61 |
chr3_37903958_37904647 | 0.75 |
CTDSPL |
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase-like |
637 |
0.58 |
chrX_10586840_10587300 | 0.75 |
MID1 |
midline 1 (Opitz/BBB syndrome) |
1389 |
0.54 |
chr18_7568558_7569022 | 0.75 |
PTPRM |
protein tyrosine phosphatase, receptor type, M |
973 |
0.7 |
chr4_89977525_89978081 | 0.74 |
FAM13A |
family with sequence similarity 13, member A |
508 |
0.85 |
chr13_24145710_24146057 | 0.73 |
TNFRSF19 |
tumor necrosis factor receptor superfamily, member 19 |
1080 |
0.66 |
chr7_116167346_116167524 | 0.73 |
CAV1 |
caveolin 1, caveolae protein, 22kDa |
1088 |
0.46 |
chr6_105628008_105628228 | 0.73 |
POPDC3 |
popeye domain containing 3 |
383 |
0.73 |
chr2_216296592_216296743 | 0.71 |
FN1 |
fibronectin 1 |
4123 |
0.25 |
chr12_3308931_3310293 | 0.71 |
TSPAN9 |
tetraspanin 9 |
729 |
0.75 |
chr6_163817634_163818149 | 0.69 |
QKI |
QKI, KH domain containing, RNA binding |
17784 |
0.29 |
chr6_112574710_112575490 | 0.69 |
LAMA4 |
laminin, alpha 4 |
587 |
0.75 |
chr8_30243504_30243875 | 0.68 |
RBPMS-AS1 |
RBPMS antisense RNA 1 |
772 |
0.48 |
chr12_66218083_66218500 | 0.68 |
HMGA2 |
high mobility group AT-hook 2 |
51 |
0.98 |
chr5_158524974_158525234 | 0.67 |
EBF1 |
early B-cell factor 1 |
1597 |
0.48 |
chr10_62332469_62332822 | 0.66 |
ANK3 |
ankyrin 3, node of Ranvier (ankyrin G) |
224 |
0.97 |
chr12_50796133_50796284 | 0.66 |
LARP4 |
La ribonucleoprotein domain family, member 4 |
1232 |
0.46 |
chr1_31380173_31380807 | 0.66 |
SDC3 |
syndecan 3 |
1118 |
0.44 |
chr11_27722222_27723091 | 0.65 |
BDNF |
brain-derived neurotrophic factor |
56 |
0.98 |
chr16_86542600_86543872 | 0.65 |
FOXF1 |
forkhead box F1 |
897 |
0.62 |
chr17_36621277_36621585 | 0.65 |
ARHGAP23 |
Rho GTPase activating protein 23 |
6749 |
0.17 |
chr1_210436119_210436432 | 0.64 |
SERTAD4-AS1 |
SERTAD4 antisense RNA 1 |
28883 |
0.18 |
chr22_46423027_46423794 | 0.64 |
RP6-109B7.5 |
|
25563 |
0.09 |
chr16_88219567_88219948 | 0.63 |
BANP |
BTG3 associated nuclear protein |
216133 |
0.02 |
chr3_40821863_40822477 | 0.63 |
ZNF621 |
zinc finger protein 621 |
255263 |
0.02 |
chr12_108991360_108991513 | 0.63 |
TMEM119 |
transmembrane protein 119 |
348 |
0.83 |
chr7_132260669_132261651 | 0.63 |
PLXNA4 |
plexin A4 |
69 |
0.98 |
chr5_55117443_55117995 | 0.62 |
IL31RA |
interleukin 31 receptor A |
29488 |
0.16 |
chr5_115790032_115790655 | 0.62 |
CTB-118N6.3 |
|
4917 |
0.26 |
chr1_32263785_32263971 | 0.62 |
SPOCD1 |
SPOC domain containing 1 |
439 |
0.79 |
chr2_66667990_66668184 | 0.62 |
MEIS1 |
Meis homeobox 1 |
277 |
0.68 |
chr3_173113877_173114225 | 0.62 |
NLGN1 |
neuroligin 1 |
23 |
0.99 |
chr2_119602557_119602736 | 0.61 |
EN1 |
engrailed homeobox 1 |
2608 |
0.39 |
chr12_118626563_118627015 | 0.61 |
TAOK3 |
TAO kinase 3 |
1538 |
0.42 |
chr16_14279913_14280368 | 0.61 |
MKL2 |
MKL/myocardin-like 2 |
434 |
0.86 |
chr1_43672267_43672508 | 0.61 |
ENSG00000199240 |
. |
10299 |
0.15 |
chr2_199965342_199965661 | 0.61 |
ENSG00000238698 |
. |
90281 |
0.1 |
chr13_36704438_36704640 | 0.61 |
DCLK1 |
doublecortin-like kinase 1 |
904 |
0.69 |
chr12_24103066_24103383 | 0.60 |
SOX5 |
SRY (sex determining region Y)-box 5 |
587 |
0.86 |
chr2_190044770_190044921 | 0.60 |
COL5A2 |
collagen, type V, alpha 2 |
240 |
0.95 |
chr4_158143046_158143598 | 0.60 |
GRIA2 |
glutamate receptor, ionotropic, AMPA 2 |
504 |
0.84 |
chr8_85096596_85096747 | 0.60 |
RALYL |
RALY RNA binding protein-like |
211 |
0.97 |
chr2_190042287_190042516 | 0.59 |
COL5A2 |
collagen, type V, alpha 2 |
2204 |
0.37 |
chr2_187406005_187406156 | 0.58 |
ZC3H15 |
zinc finger CCCH-type containing 15 |
34640 |
0.15 |
chr3_161883614_161883765 | 0.58 |
OTOL1 |
otolin 1 |
669093 |
0.0 |
chrX_22318596_22318928 | 0.58 |
ZNF645 |
zinc finger protein 645 |
27697 |
0.24 |
chr6_105388737_105389249 | 0.57 |
LIN28B |
lin-28 homolog B (C. elegans) |
15930 |
0.23 |
chr18_53089837_53090372 | 0.57 |
TCF4 |
transcription factor 4 |
361 |
0.89 |
chr19_47473743_47473975 | 0.57 |
ENSG00000252071 |
. |
22313 |
0.15 |
chr10_45473591_45473742 | 0.57 |
C10orf10 |
chromosome 10 open reading frame 10 |
571 |
0.64 |
chr4_152246816_152247200 | 0.57 |
ENSG00000252544 |
. |
25338 |
0.19 |
chr9_79520622_79521003 | 0.56 |
PRUNE2 |
prune homolog 2 (Drosophila) |
189 |
0.97 |
chr18_73350466_73350705 | 0.56 |
SMIM21 |
small integral membrane protein 21 |
210927 |
0.02 |
chr8_85095169_85095335 | 0.56 |
RALYL |
RALY RNA binding protein-like |
230 |
0.97 |
chr3_123476244_123476543 | 0.56 |
MYLK |
myosin light chain kinase |
36295 |
0.15 |
chrX_107179250_107179655 | 0.56 |
RP6-191P20.4 |
|
242 |
0.93 |
chr10_104536560_104536809 | 0.56 |
WBP1L |
WW domain binding protein 1-like |
678 |
0.63 |
chr7_82073407_82073821 | 0.55 |
CACNA2D1 |
calcium channel, voltage-dependent, alpha 2/delta subunit 1 |
500 |
0.89 |
chr13_31271674_31272060 | 0.55 |
ALOX5AP |
arachidonate 5-lipoxygenase-activating protein |
37778 |
0.19 |
chr5_58592476_58593460 | 0.55 |
PDE4D |
phosphodiesterase 4D, cAMP-specific |
21023 |
0.29 |
chr13_76212170_76212445 | 0.55 |
LMO7 |
LIM domain 7 |
1848 |
0.28 |
chr13_111452203_111452465 | 0.55 |
LINC00346 |
long intergenic non-protein coding RNA 346 |
69828 |
0.1 |
chr1_29563184_29564088 | 0.54 |
PTPRU |
protein tyrosine phosphatase, receptor type, U |
485 |
0.75 |
chr13_103054295_103054752 | 0.54 |
FGF14 |
fibroblast growth factor 14 |
399 |
0.89 |
chr6_125932782_125933099 | 0.54 |
RP11-624M8.1 |
|
133234 |
0.05 |
chr10_79685105_79685313 | 0.54 |
DLG5 |
discs, large homolog 5 (Drosophila) |
1075 |
0.43 |
chr4_170189564_170189726 | 0.54 |
SH3RF1 |
SH3 domain containing ring finger 1 |
1463 |
0.54 |
chr15_96883311_96883827 | 0.54 |
ENSG00000222651 |
. |
7079 |
0.16 |
chr10_118547485_118547701 | 0.54 |
HSPA12A |
heat shock 70kDa protein 12A |
45508 |
0.14 |
chr9_91433553_91433929 | 0.54 |
ENSG00000265873 |
. |
72921 |
0.12 |
chrX_20135177_20135375 | 0.53 |
MAP7D2 |
MAP7 domain containing 2 |
241 |
0.9 |
chr16_10673584_10673860 | 0.53 |
EMP2 |
epithelial membrane protein 2 |
833 |
0.54 |
chrX_109987052_109987203 | 0.53 |
CHRDL1 |
chordin-like 1 |
51866 |
0.18 |
chr21_32720000_32720175 | 0.53 |
TIAM1 |
T-cell lymphoma invasion and metastasis 1 |
3493 |
0.37 |
chr5_88185268_88186094 | 0.52 |
MEF2C-AS1 |
MEF2C antisense RNA 1 |
404 |
0.88 |
chr6_112651357_112651565 | 0.52 |
RFPL4B |
ret finger protein-like 4B |
17071 |
0.19 |
chr5_33937092_33937273 | 0.51 |
RXFP3 |
relaxin/insulin-like family peptide receptor 3 |
691 |
0.7 |
chr9_129884150_129884930 | 0.51 |
ANGPTL2 |
angiopoietin-like 2 |
373 |
0.9 |
chr2_216299709_216300678 | 0.51 |
FN1 |
fibronectin 1 |
597 |
0.55 |
chr19_15219133_15219284 | 0.51 |
SYDE1 |
synapse defective 1, Rho GTPase, homolog 1 (C. elegans) |
436 |
0.73 |
chr2_198538241_198538478 | 0.50 |
RFTN2 |
raftlin family member 2 |
2360 |
0.29 |
chr12_66221542_66221865 | 0.50 |
HMGA2 |
high mobility group AT-hook 2 |
2800 |
0.29 |
chrX_17431119_17431354 | 0.50 |
ENSG00000265465 |
. |
12768 |
0.22 |
chr3_112931196_112931871 | 0.50 |
BOC |
BOC cell adhesion associated, oncogene regulated |
124 |
0.97 |
chr20_58164973_58165317 | 0.50 |
PHACTR3 |
phosphatase and actin regulator 3 |
12581 |
0.25 |
chr19_11892320_11892471 | 0.50 |
ZNF441 |
zinc finger protein 441 |
14488 |
0.11 |
chr6_46816549_46816814 | 0.50 |
GPR116 |
G protein-coupled receptor 116 |
22921 |
0.18 |
chr17_25886913_25887375 | 0.50 |
KSR1 |
kinase suppressor of ras 1 |
22803 |
0.19 |
chr3_173113317_173113831 | 0.49 |
NLGN1 |
neuroligin 1 |
500 |
0.89 |
chr17_56401899_56402577 | 0.49 |
BZRAP1-AS1 |
BZRAP1 antisense RNA 1 |
573 |
0.61 |
chr3_65818040_65818191 | 0.49 |
MAGI1-AS1 |
MAGI1 antisense RNA 1 |
61376 |
0.14 |
chr19_10120368_10120847 | 0.49 |
COL5A3 |
collagen, type V, alpha 3 |
540 |
0.61 |
chr11_66083364_66083632 | 0.49 |
CD248 |
CD248 molecule, endosialin |
1017 |
0.24 |
chr11_27719069_27719230 | 0.48 |
BDNF |
brain-derived neurotrophic factor |
2065 |
0.4 |
chr14_27453693_27453844 | 0.48 |
ENSG00000222899 |
. |
56909 |
0.15 |
chr8_99439239_99439631 | 0.48 |
KCNS2 |
potassium voltage-gated channel, delayed-rectifier, subfamily S, member 2 |
185 |
0.95 |
chr11_85885739_85885890 | 0.47 |
ENSG00000200877 |
. |
21545 |
0.2 |
chr8_19459484_19459946 | 0.47 |
CSGALNACT1 |
chondroitin sulfate N-acetylgalactosaminyltransferase 1 |
291 |
0.95 |
chr22_24640119_24640309 | 0.47 |
GGT5 |
gamma-glutamyltransferase 5 |
813 |
0.59 |
chr3_120167855_120168016 | 0.47 |
FSTL1 |
follistatin-like 1 |
1903 |
0.44 |
chr8_125673018_125673304 | 0.47 |
MTSS1 |
metastasis suppressor 1 |
66696 |
0.11 |
chr17_28847050_28847209 | 0.47 |
TBC1D29 |
TBC1 domain family, member 29 |
37001 |
0.11 |
chr18_75239336_75239487 | 0.47 |
ENSG00000199392 |
. |
95766 |
0.09 |
chr20_17207159_17207414 | 0.47 |
PCSK2 |
proprotein convertase subtilisin/kexin type 2 |
350 |
0.89 |
chr8_22241251_22241835 | 0.47 |
SLC39A14 |
solute carrier family 39 (zinc transporter), member 14 |
8800 |
0.18 |
chr6_21597329_21597632 | 0.47 |
SOX4 |
SRY (sex determining region Y)-box 4 |
3409 |
0.4 |
chr3_52568044_52568870 | 0.47 |
NT5DC2 |
5'-nucleotidase domain containing 2 |
613 |
0.56 |
chr2_8143991_8144314 | 0.47 |
ENSG00000221255 |
. |
427180 |
0.01 |
chr8_118743734_118743992 | 0.47 |
MED30 |
mediator complex subunit 30 |
210791 |
0.02 |
chr17_2027134_2027389 | 0.47 |
RP11-667K14.5 |
|
34286 |
0.09 |
chr20_36450419_36450584 | 0.47 |
CTNNBL1 |
catenin, beta like 1 |
44826 |
0.16 |
chr16_88338697_88338848 | 0.47 |
ZNF469 |
zinc finger protein 469 |
155107 |
0.03 |
chr6_12718315_12718575 | 0.46 |
PHACTR1 |
phosphatase and actin regulator 1 |
97 |
0.98 |
chr10_15760270_15760566 | 0.46 |
ITGA8 |
integrin, alpha 8 |
1706 |
0.51 |
chrX_39377843_39378107 | 0.46 |
ENSG00000263730 |
. |
142495 |
0.05 |
chr19_30719772_30720177 | 0.46 |
AC005597.1 |
|
352 |
0.63 |
chr20_10900984_10901135 | 0.46 |
RP11-103J8.1 |
|
18127 |
0.28 |
chr7_27202641_27202952 | 0.46 |
HOXA9 |
homeobox A9 |
2349 |
0.09 |
chr13_99563225_99563376 | 0.45 |
DOCK9 |
dedicator of cytokinesis 9 |
55062 |
0.13 |
chr12_96230499_96230719 | 0.45 |
RP11-536G4.2 |
|
21967 |
0.13 |
chr8_58908290_58908441 | 0.45 |
FAM110B |
family with sequence similarity 110, member B |
1252 |
0.65 |
chr4_16900069_16900243 | 0.45 |
LDB2 |
LIM domain binding 2 |
29 |
0.99 |
chr7_121513447_121513715 | 0.45 |
PTPRZ1 |
protein tyrosine phosphatase, receptor-type, Z polypeptide 1 |
166 |
0.97 |
chr22_46468942_46469448 | 0.45 |
RP6-109B7.4 |
|
3424 |
0.12 |
chr10_91294704_91295240 | 0.44 |
SLC16A12 |
solute carrier family 16, member 12 |
341 |
0.89 |
chr2_188406887_188407185 | 0.44 |
AC007319.1 |
|
11840 |
0.23 |
chr8_114449888_114450066 | 0.44 |
CSMD3 |
CUB and Sushi multiple domains 3 |
649 |
0.8 |
chr3_112359324_112359570 | 0.44 |
CCDC80 |
coiled-coil domain containing 80 |
669 |
0.77 |
chr12_24716473_24716754 | 0.44 |
ENSG00000240481 |
. |
143109 |
0.05 |
chr8_42063953_42065062 | 0.44 |
PLAT |
plasminogen activator, tissue |
576 |
0.71 |
chr17_35854577_35854849 | 0.44 |
DUSP14 |
dual specificity phosphatase 14 |
3143 |
0.25 |
chr3_21789745_21789896 | 0.43 |
ZNF385D |
zinc finger protein 385D |
3107 |
0.38 |
chr1_231002889_231003524 | 0.43 |
C1orf198 |
chromosome 1 open reading frame 198 |
1193 |
0.37 |
chr1_213226134_213226428 | 0.43 |
RPS6KC1 |
ribosomal protein S6 kinase, 52kDa, polypeptide 1 |
1677 |
0.45 |
chr9_16267652_16267856 | 0.43 |
C9orf92 |
chromosome 9 open reading frame 92 |
8557 |
0.32 |
chr4_62068507_62068658 | 0.43 |
LPHN3 |
latrophilin 3 |
722 |
0.82 |
chr2_166430745_166430996 | 0.43 |
CSRNP3 |
cysteine-serine-rich nuclear protein 3 |
251 |
0.96 |
chr5_88168642_88169029 | 0.43 |
MEF2C |
myocyte enhancer factor 2C |
4959 |
0.27 |
chr6_152085356_152085807 | 0.43 |
ESR1 |
estrogen receptor 1 |
39985 |
0.18 |
chr10_120454277_120454428 | 0.43 |
CACUL1 |
CDK2-associated, cullin domain 1 |
60406 |
0.11 |
chr11_133944452_133944603 | 0.43 |
JAM3 |
junctional adhesion molecule 3 |
5561 |
0.26 |
chr8_13369656_13370025 | 0.43 |
DLC1 |
deleted in liver cancer 1 |
2434 |
0.32 |
chr10_77229198_77229525 | 0.43 |
RP11-399K21.10 |
|
38015 |
0.16 |
chr17_25785381_25785532 | 0.42 |
KSR1 |
kinase suppressor of ras 1 |
1716 |
0.37 |
chr11_74177997_74178329 | 0.42 |
KCNE3 |
potassium voltage-gated channel, Isk-related family, member 3 |
431 |
0.77 |
chr1_14106721_14106872 | 0.42 |
PRDM2 |
PR domain containing 2, with ZNF domain |
8575 |
0.27 |
chr20_52534251_52534460 | 0.42 |
AC005220.3 |
|
22344 |
0.24 |
chr3_36805291_36805678 | 0.42 |
DCLK3 |
doublecortin-like kinase 3 |
24132 |
0.23 |
chr9_124262101_124262557 | 0.42 |
ENSG00000240299 |
. |
5532 |
0.22 |
chr9_16704056_16704545 | 0.42 |
BNC2 |
basonuclin 2 |
780 |
0.71 |
chr2_210444245_210444440 | 0.42 |
MAP2 |
microtubule-associated protein 2 |
9 |
0.99 |
chr4_113970775_113971222 | 0.41 |
ANK2 |
ankyrin 2, neuronal |
113 |
0.97 |
chrX_53078746_53079004 | 0.41 |
GPR173 |
G protein-coupled receptor 173 |
410 |
0.85 |
chr15_37390103_37390360 | 0.41 |
MEIS2 |
Meis homeobox 2 |
272 |
0.88 |
chrX_24664424_24664575 | 0.41 |
PCYT1B |
phosphate cytidylyltransferase 1, choline, beta |
776 |
0.62 |
chr5_97903857_97904008 | 0.41 |
ENSG00000223053 |
. |
71003 |
0.13 |
chr13_24132983_24133158 | 0.41 |
TNFRSF19 |
tumor necrosis factor receptor superfamily, member 19 |
11439 |
0.29 |
chr15_65714510_65715080 | 0.41 |
IGDCC4 |
immunoglobulin superfamily, DCC subclass, member 4 |
615 |
0.71 |
chr11_6676307_6676669 | 0.41 |
DCHS1 |
dachsous cadherin-related 1 |
597 |
0.56 |
chr16_29231357_29231508 | 0.41 |
RP11-231C14.6 |
|
92239 |
0.06 |
chr7_11579827_11580194 | 0.40 |
AC004160.4 |
|
133428 |
0.05 |
chr3_87030882_87031292 | 0.40 |
VGLL3 |
vestigial like 3 (Drosophila) |
8765 |
0.33 |
chr2_65041018_65041169 | 0.40 |
ENSG00000239891 |
. |
3419 |
0.23 |
chr2_178160613_178160764 | 0.40 |
RP11-337N6.2 |
|
4640 |
0.13 |
chr1_224615016_224615209 | 0.40 |
WDR26 |
WD repeat domain 26 |
6695 |
0.2 |
chr2_33516692_33517051 | 0.40 |
LTBP1 |
latent transforming growth factor beta binding protein 1 |
156 |
0.96 |
chr18_56531608_56531759 | 0.40 |
ZNF532 |
zinc finger protein 532 |
42 |
0.98 |
chr3_106279877_106280028 | 0.40 |
ENSG00000200610 |
. |
45208 |
0.2 |
chr6_7543759_7543937 | 0.40 |
DSP |
desmoplakin |
1998 |
0.3 |
chr8_21494840_21495147 | 0.40 |
ENSG00000266630 |
. |
87484 |
0.09 |
chr2_105458782_105459564 | 0.40 |
LINC01158 |
long intergenic non-protein coding RNA 1158 |
8738 |
0.14 |
chr11_75276408_75276721 | 0.40 |
SERPINH1 |
serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1) |
2097 |
0.24 |
chr5_14442202_14442353 | 0.40 |
TRIO |
trio Rho guanine nucleotide exchange factor |
46280 |
0.19 |
chr3_71553679_71554070 | 0.40 |
ENSG00000221264 |
. |
37366 |
0.17 |
chr12_89777470_89777621 | 0.40 |
DUSP6 |
dual specificity phosphatase 6 |
30497 |
0.2 |
chr12_95840276_95840427 | 0.40 |
ENSG00000222544 |
. |
7732 |
0.2 |
chr5_36607641_36607792 | 0.39 |
SLC1A3 |
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
564 |
0.85 |
chr12_72665374_72665945 | 0.39 |
ENSG00000236333 |
. |
112 |
0.93 |
chr3_112355518_112355669 | 0.39 |
CCDC80 |
coiled-coil domain containing 80 |
1351 |
0.52 |
chr6_43742717_43743167 | 0.39 |
VEGFA |
vascular endothelial growth factor A |
852 |
0.59 |
chr15_92937732_92938190 | 0.39 |
ST8SIA2 |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2 |
666 |
0.74 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.2 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.3 | 1.0 | GO:0035581 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.2 | 0.5 | GO:0010842 | retina layer formation(GO:0010842) |
0.2 | 0.5 | GO:0031223 | auditory behavior(GO:0031223) |
0.2 | 1.4 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.2 | 1.1 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 0.4 | GO:0002887 | negative regulation of myeloid leukocyte mediated immunity(GO:0002887) negative regulation of leukocyte degranulation(GO:0043301) |
0.1 | 0.5 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.1 | 0.3 | GO:1904936 | interneuron migration from the subpallium to the cortex(GO:0021830) cerebral cortex GABAergic interneuron migration(GO:0021853) cerebral cortex GABAergic interneuron development(GO:0021894) interneuron migration(GO:1904936) |
0.1 | 0.3 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.1 | 1.2 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.1 | 0.4 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 0.4 | GO:0060754 | mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) |
0.1 | 0.3 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.1 | 0.3 | GO:0008049 | male courtship behavior(GO:0008049) |
0.1 | 0.3 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.1 | GO:1903224 | endodermal cell fate commitment(GO:0001711) endodermal cell fate specification(GO:0001714) endodermal cell differentiation(GO:0035987) regulation of endodermal cell fate specification(GO:0042663) regulation of endodermal cell differentiation(GO:1903224) |
0.1 | 0.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.5 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.1 | 0.3 | GO:0072070 | loop of Henle development(GO:0072070) |
0.1 | 0.4 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.1 | 0.2 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.1 | 0.1 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.1 | 0.2 | GO:0044557 | relaxation of smooth muscle(GO:0044557) relaxation of vascular smooth muscle(GO:0060087) |
0.1 | 0.6 | GO:0045176 | apical protein localization(GO:0045176) |
0.1 | 0.2 | GO:0060596 | mammary placode formation(GO:0060596) |
0.1 | 0.2 | GO:0061072 | iris morphogenesis(GO:0061072) |
0.1 | 0.3 | GO:0060737 | prostate gland morphogenetic growth(GO:0060737) |
0.1 | 0.5 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.1 | 1.7 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 0.2 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.1 | 0.5 | GO:1901532 | regulation of megakaryocyte differentiation(GO:0045652) regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
0.1 | 0.5 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.1 | 1.0 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.1 | 0.2 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.1 | 0.2 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.1 | 0.8 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 0.1 | GO:0060677 | ureteric bud elongation(GO:0060677) |
0.1 | 0.4 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.1 | 0.4 | GO:0031000 | response to caffeine(GO:0031000) |
0.1 | 0.2 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.1 | 0.2 | GO:0060992 | response to fungicide(GO:0060992) |
0.1 | 0.2 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.2 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.1 | 0.2 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.2 | GO:0010757 | regulation of plasminogen activation(GO:0010755) negative regulation of plasminogen activation(GO:0010757) |
0.1 | 0.1 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.2 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.1 | 1.2 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.1 | 0.4 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.0 | 0.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.0 | 0.2 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 0.1 | GO:0060431 | primary lung bud formation(GO:0060431) |
0.0 | 0.0 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.0 | 0.4 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.3 | GO:0016264 | gap junction assembly(GO:0016264) |
0.0 | 0.1 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.0 | 0.2 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.0 | 0.1 | GO:1900078 | positive regulation of insulin receptor signaling pathway(GO:0046628) positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.0 | 0.1 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) positive regulation of melanocyte differentiation(GO:0045636) regulation of pigment cell differentiation(GO:0050932) positive regulation of pigment cell differentiation(GO:0050942) |
0.0 | 0.2 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.0 | 0.2 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
0.0 | 0.1 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.1 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.0 | 0.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.1 | GO:0071436 | sodium ion export(GO:0071436) |
0.0 | 0.5 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.0 | 0.2 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.0 | 0.1 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.0 | 0.1 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.0 | 0.1 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.0 | 0.1 | GO:0016103 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
0.0 | 0.3 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.1 | GO:0010587 | miRNA metabolic process(GO:0010586) miRNA catabolic process(GO:0010587) |
0.0 | 0.1 | GO:0072044 | collecting duct development(GO:0072044) metanephric collecting duct development(GO:0072205) |
0.0 | 0.2 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 0.6 | GO:0042730 | fibrinolysis(GO:0042730) |
0.0 | 0.3 | GO:0043266 | regulation of potassium ion transport(GO:0043266) |
0.0 | 0.2 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.0 | 0.2 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.0 | GO:0090047 | obsolete positive regulation of transcription regulator activity(GO:0090047) |
0.0 | 0.1 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.0 | 0.3 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.0 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.0 | 0.1 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.0 | 0.5 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.0 | 0.1 | GO:0033197 | response to vitamin E(GO:0033197) |
0.0 | 0.1 | GO:0071267 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.0 | 0.4 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.0 | 0.1 | GO:0061001 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.0 | 0.0 | GO:0060484 | bronchus development(GO:0060433) lung-associated mesenchyme development(GO:0060484) |
0.0 | 0.1 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.1 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.0 | 0.1 | GO:0021521 | ventral spinal cord interneuron differentiation(GO:0021514) ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
0.0 | 0.0 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.0 | 0.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.0 | 0.1 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.0 | 0.1 | GO:1903672 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) positive regulation of sprouting angiogenesis(GO:1903672) |
0.0 | 0.7 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 | 0.1 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.1 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.0 | 0.1 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.0 | 0.0 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.0 | 0.1 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.0 | 0.2 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.0 | 0.5 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.0 | 0.1 | GO:0060287 | epithelial cilium movement(GO:0003351) epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.0 | 0.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.0 | 0.3 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.0 | 0.1 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.0 | 0.0 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.0 | 0.0 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.0 | 0.1 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.0 | 0.0 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.0 | 0.0 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.2 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.1 | GO:0055057 | neuronal stem cell division(GO:0036445) neuroblast division(GO:0055057) |
0.0 | 0.1 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.0 | 0.0 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.0 | 0.1 | GO:0071674 | positive regulation of macrophage chemotaxis(GO:0010759) mononuclear cell migration(GO:0071674) regulation of mononuclear cell migration(GO:0071675) |
0.0 | 0.3 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.0 | 0.1 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.1 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.0 | 0.0 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.0 | 0.1 | GO:0034393 | positive regulation of muscle cell apoptotic process(GO:0010661) positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.0 | 0.1 | GO:0055015 | ventricular cardiac muscle cell development(GO:0055015) |
0.0 | 0.1 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.0 | 0.0 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.3 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.0 | 0.1 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.0 | 0.1 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
0.0 | 0.1 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.0 | 0.4 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.0 | 0.0 | GO:0061042 | vascular wound healing(GO:0061042) regulation of vascular wound healing(GO:0061043) |
0.0 | 0.5 | GO:0051318 | G1 phase(GO:0051318) |
0.0 | 0.1 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.0 | 0.0 | GO:0043501 | skeletal muscle adaptation(GO:0043501) |
0.0 | 0.2 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.1 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.0 | 0.1 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.0 | 0.0 | GO:0090037 | regulation of protein kinase C signaling(GO:0090036) positive regulation of protein kinase C signaling(GO:0090037) |
0.0 | 0.2 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.0 | 0.0 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.0 | 0.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.1 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.1 | GO:0006188 | IMP biosynthetic process(GO:0006188) IMP metabolic process(GO:0046040) |
0.0 | 0.0 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.0 | 0.0 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.0 | 0.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.0 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.0 | 0.1 | GO:0002076 | osteoblast development(GO:0002076) |
0.0 | 0.1 | GO:0048844 | artery morphogenesis(GO:0048844) |
0.0 | 0.0 | GO:0002407 | dendritic cell chemotaxis(GO:0002407) dendritic cell migration(GO:0036336) |
0.0 | 0.2 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.0 | 0.1 | GO:1901862 | negative regulation of muscle tissue development(GO:1901862) |
0.0 | 0.1 | GO:1901863 | positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
0.0 | 0.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.0 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.1 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.0 | 0.0 | GO:0010662 | striated muscle cell apoptotic process(GO:0010658) cardiac muscle cell apoptotic process(GO:0010659) regulation of striated muscle cell apoptotic process(GO:0010662) negative regulation of striated muscle cell apoptotic process(GO:0010664) regulation of cardiac muscle cell apoptotic process(GO:0010665) negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.0 | 0.1 | GO:0090303 | positive regulation of wound healing(GO:0090303) |
0.0 | 0.1 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.0 | 0.0 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.0 | 0.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.0 | GO:0072162 | mesenchymal cell differentiation involved in kidney development(GO:0072161) metanephric mesenchymal cell differentiation(GO:0072162) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.0 | 0.0 | GO:0060913 | cardiac cell fate determination(GO:0060913) |
0.0 | 0.1 | GO:0006553 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.0 | 0.0 | GO:0019228 | neuronal action potential(GO:0019228) |
0.0 | 0.1 | GO:0019359 | nicotinamide nucleotide biosynthetic process(GO:0019359) |
0.0 | 0.1 | GO:0006906 | vesicle fusion(GO:0006906) |
0.0 | 0.1 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.0 | 0.0 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.0 | 0.0 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.0 | 0.0 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.0 | 0.0 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.0 | 0.0 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 0.0 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.0 | 0.0 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 0.0 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.0 | 0.2 | GO:0001508 | action potential(GO:0001508) |
0.0 | 0.1 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.0 | 0.0 | GO:0043620 | regulation of DNA-templated transcription in response to stress(GO:0043620) |
0.0 | 0.2 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.1 | GO:0046321 | positive regulation of fatty acid oxidation(GO:0046321) |
0.0 | 0.0 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.0 | 0.0 | GO:0048617 | embryonic foregut morphogenesis(GO:0048617) |
0.0 | 0.2 | GO:0000045 | autophagosome assembly(GO:0000045) autophagosome organization(GO:1905037) |
0.0 | 0.0 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.0 | 0.1 | GO:0048566 | embryonic digestive tract development(GO:0048566) |
0.0 | 0.0 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) myosin filament assembly(GO:0031034) striated muscle myosin thick filament assembly(GO:0071688) |
0.0 | 0.0 | GO:0021754 | facial nucleus development(GO:0021754) |
0.0 | 0.2 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 0.0 | GO:0008356 | asymmetric cell division(GO:0008356) |
0.0 | 0.0 | GO:0003341 | cilium movement(GO:0003341) |
0.0 | 0.2 | GO:0021766 | hippocampus development(GO:0021766) |
0.0 | 0.2 | GO:0008038 | neuron recognition(GO:0008038) |
0.0 | 0.1 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.0 | GO:0051446 | positive regulation of meiotic nuclear division(GO:0045836) positive regulation of meiotic cell cycle(GO:0051446) |
0.0 | 0.0 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.0 | 0.0 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.4 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.1 | 0.9 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.1 | 0.9 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.4 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.1 | 0.6 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.1 | 0.7 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.4 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 0.3 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.1 | 0.8 | GO:0043205 | fibril(GO:0043205) |
0.1 | 0.3 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.1 | 0.2 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 0.3 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 0.7 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 0.2 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 1.2 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 0.1 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 0.2 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 0.2 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.0 | 0.2 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.2 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.2 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.0 | 0.0 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 0.3 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.0 | 0.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.3 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.2 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.2 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 0.6 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.1 | GO:0001739 | sex chromatin(GO:0001739) |
0.0 | 0.4 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.1 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.0 | 0.0 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.0 | 0.5 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.0 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 0.1 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.0 | 0.2 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.0 | 1.3 | GO:0060076 | excitatory synapse(GO:0060076) |
0.0 | 0.2 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 0.1 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.3 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.1 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.1 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 3.8 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.0 | GO:0032449 | CBM complex(GO:0032449) |
0.0 | 0.5 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.0 | 0.1 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 0.1 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.0 | 0.1 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.1 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.0 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.0 | 0.9 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 0.6 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.2 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.9 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.2 | 0.7 | GO:0003680 | AT DNA binding(GO:0003680) |
0.2 | 1.4 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 0.5 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.8 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 1.2 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 0.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.3 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.1 | 0.3 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 0.7 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.1 | 0.7 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 0.4 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 0.2 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 0.4 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.1 | 0.3 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.1 | 0.4 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.1 | 0.3 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.1 | 0.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 0.4 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.1 | 0.3 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.1 | 0.5 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 0.2 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 4.3 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.2 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.4 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.3 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 0.6 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.5 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.7 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 1.2 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.0 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.0 | 0.4 | GO:0008143 | poly(A) binding(GO:0008143) |
0.0 | 0.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.0 | 0.4 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.3 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.0 | 0.3 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.2 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.5 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.0 | 0.3 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.0 | 0.1 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 0.2 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.2 | GO:0042805 | actinin binding(GO:0042805) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.0 | 0.3 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.2 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.0 | 0.3 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) |
0.0 | 0.1 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.0 | 0.1 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.0 | 0.2 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.0 | 0.1 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.1 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.3 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.0 | 0.5 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.2 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.1 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.0 | 0.1 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.0 | 0.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.0 | 0.1 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.0 | 0.2 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 0.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.1 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.0 | 0.6 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.0 | 0.1 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 0.2 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
0.0 | 0.1 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.3 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 0.2 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 0.3 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.0 | 0.1 | GO:0001012 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) RNA polymerase II regulatory region DNA binding(GO:0001012) |
0.0 | 0.1 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.0 | 0.1 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.0 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.4 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.0 | 0.1 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.0 | 0.1 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.0 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.2 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.0 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.0 | 0.0 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.0 | 0.1 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.0 | 0.1 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.0 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.0 | 0.0 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.0 | 0.1 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.0 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.2 | GO:0030553 | cGMP binding(GO:0030553) |
0.0 | 0.0 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
0.0 | 0.1 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.0 | 0.0 | GO:0034595 | phosphatidylinositol phosphate 5-phosphatase activity(GO:0034595) |
0.0 | 0.1 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.0 | 0.1 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 0.1 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.0 | 0.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.0 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.0 | 0.1 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.0 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.0 | 0.1 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 0.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.2 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.0 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.0 | 0.0 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.1 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.0 | 0.1 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 0.2 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.1 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 0.3 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.2 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.2 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.1 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.1 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.0 | 0.2 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 0.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 0.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.0 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.1 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 0.0 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.0 | 0.1 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 0.1 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.0 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.0 | 0.0 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.1 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.0 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.1 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 0.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 1.9 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 2.1 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.4 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.2 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.8 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.6 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.4 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 1.1 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.4 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.8 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.7 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.6 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.2 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.6 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.2 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.3 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.1 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 1.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 1.2 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 2.2 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 1.1 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.1 | 1.0 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.7 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.0 | 2.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.2 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.0 | 0.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.0 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.5 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 0.0 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.2 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 1.0 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.4 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.5 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.2 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.0 | 0.1 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.1 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.0 | 0.3 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.5 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 0.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.3 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.0 | 0.2 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.1 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.0 | 0.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.2 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.0 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.0 | 0.2 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 0.2 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.1 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.1 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.1 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.1 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.1 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.1 | REACTOME S PHASE | Genes involved in S Phase |
0.0 | 0.1 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.2 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.1 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.0 | 0.2 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |